Inside Financial Connections Newsletter
- WILL THE U.S. LEAD THE GLOBAL ECONOMIC RECOVERY?
- mRNA AND THE POTENTIAL FOR FUTURE CURES
- CRYPTOCURRENCIES AKA DIGITAL CURRENCIES
- ECONOMY MOVING FORWARD
April 12, 2021
WAY TO GO DANIELLE!
Please join us in congratulating Danielle. After only one year with Financial Connections, she passed her exam to become a Financial Paraplanner Qualified Professional (FPQP™). She will be assisting us with financial plans.
We are a resilient nation. Our economy bounced back sooner than most developed countries from the impact of the Great Recession. It looks like we may be a leader bouncing back from the pandemic as well.
According to Oxford Economics, a combination of:
puts the U.S. on a fast track to pre-pandemic economic activity. And, frosting on the cake, American households have $1.8 trillion of excess savings. Pent up spending will help the recovery as herd immunity gains traction and business starts re-opening.
Since 2008, China was the major global growth economy. Oxford Economics anticipates the U.S. will surpass China this year – a feat not accomplished since 2005.
According to Catherine Mann, global chief economist at Citibank, “The U.S. is going to play the role of the global locomotive again in 2021.”
We know it seems that messenger RNA, a synthetic technology, appeared on the COVID-19 scene out of nowhere. Actually, it started almost 40 years ago. The basic principle of mRNA is very simple. Let’s use the most powerful drug factory known – our own body.
The goal is to instruct our cells to make proteins for some task – in this case, fight COVID-19. We’ve all seen the spike molecule that represents the virus. These vaccines instruct the cells to make a “spike protein.” Once available, if the virus enters our body, the mRNA recognizes it and triggers the immune system attack to block it before the virus can enter cells.
Why all of a sudden were the vaccines able to be used so quickly? There are many reasons but some of the primary ones are:
Where to now?
With the framework of mRNA technology, the following potential vaccines are being created.
It used to take an average of 10 years to develop a vaccine. COVID-19 was done in a year. Hopefully what we learned will help prevent, control, and cure other diseases.
There is a lot of media coverage about cryptocurrencies. Most inquiries we’ve received are about Bitcoin. Other popular ones are Dogecoin, Ethereum, XPR, Tether, and Litecoin.
According to Wikipedia.org, cryptocurrency is a type of currency which uses digital files as money. Cryptocurrencies use “decentralized control”, which means that they aren’t controlled by one person, company or government.
There are actually over 6,700 cryptocurrencies. They are unregulated. There is no central authority. There are no banks. There is no Federal Reserve.
Your cryptocurrency is stored in what is called a “digital wallet” on your phone, computer or cloud. You can pay, if cryptocurrency is accepted, via electronic devices.
Cryptocurrency prices constantly change. They are very volatile. Your purchase of a unit at $1,000 could be worth $800 tomorrow or $1,200.
According to Roger Aliaga-Diaz, chief economist for the Americas and head of portfolio construction at Vanguard, cryptocurrency is speculation, not investment.
Without a central bank which preserves the value of the currency, the cryptocurrency price continues its volatility. You forego the consistency of a dollar being worth the same this year and future years.
Other potential concerns:
Liquidity – If you try to sell your digital currency, there needs to be a buyer. However, there is no regulation requiring someone to buy.
Pricing – Again, no regulation and no way to have a unit equal a consistent price.
Regulatory – There may come a time when governments try to regulate digital currency. Regulation could adversely reflect cryptocurrency pricing though it might stabilize it.
Security risk – In 2019, 12 cryptocurrency exchanges were hacked. One individual said he lost $100,000 because of a SIM-swapping hack. His Coinbase account was wiped clean.
This may change in the future. Central Banks are beginning to study the potential of issuing government digital currency. JP Morgan is investigating issuing digital currency. China, as an experiment, handed out digital currency to the tune of 10 million yuan (approximately $1.5 million) to one of its provinces. It is an experiment to see how it works with over 3,000 merchants accepting digital payment.
Stay tuned. This is a rapidly evolving area.
There is consensus that the rescue plan is going to give a large boost to our economy this year; but forecasting beyond that will be difficult for some of the following reasons.
Combine the lack of history for all these points and educated guesses might be moving into the speculative category.
At this time
We know that 62% of jobs have been recovered from pre-pandemic levels. This time next year, unemployment is expected to be at pre-pandemic levels (around 4% or lower).
Longer-term interest rates have risen even though the Fed says they aren’t planning to raise interest rates until 2023. The market doesn’t believe them. Hence the longer-term interest rates rising. Other reason – investors are assuming higher inflation.
The $1.9 Trillion Rescue package will turbocharge the economy short-term. Lower income wage earners spend 99% of the income and more income will be distributed from the legislation.
Herd immunity could be reached by early summer and permit more businesses to re-open.
Expected Returns per JP Morgan
The Price/Earnings (P/E) is high (stock valuations). Interest rates are low. The earnings yield on a stock is defined as the inverse of the P/E ratio and is representative of future returns.
If you were to take the earnings yield on the S&P 500 forward earnings of 0.4 times and the yield from the Barclays Aggregate Bond Index, a portfolio of 60% U.S. Equities and 40% U.S. bonds would return 3.21% per year.
Financial Connections Portfolios
We diversify more than just large U.S. equities and bonds. Your portfolios may have small companies, international (developed and emerging markets), alternative strategies, and diversified bond funds.
With this newsletter and reports, we also include our annual ADV 2 and 3. Please let us know if you have any questions or would like to update your plans.
Financial Connections makes its staff available to journalists to share knowledge.
READ MORENo Hidden Costs. No Referral Fees. No Commissions.
As a fiduciary, we put our clients' interests first. Our compensation comes exclusively from you. If we don't directly provide a particular service, we can serve as a resource for referrals to other professionals.
Download the fee schedule Download Disclosure Form ADV Parts 2 & 3You are leaving www.FinancialConnections.com and will be automatically redirected to the link you clicked.
Changed your mind? Go back to www.FinancialConnections.com
You are now leaving the "Financial Connections" Website and will be entering the Charles Schwab & Co., Inc. ("Schwab") Website.
Schwab is a registered broker-dealer, and is not affiliated with "Financial Connections Group, Inc." or any advisor(s) whose name(s) appears on this Website. "Financial Connections Group, Inc." is/are independently owned and operated. Schwab neither endorses nor recommends Financial Connections, unless you have been referred to us through the Schwab Advisor Network®. Regardless of any referral or recommendation, Schwab does not endorse or recommend the investment strategy of any advisor. Schwab has agreements with "Financial Connections Group, Inc." under which Schwab provides “Financial Connections Group, Inc.” with services related to your account. Schwab does not review the "Financial Connections Group, Inc." Website(s), and makes no representation regarding the content of the Website(s). The information contained in the "Financial Connections Group, Inc." Website should not be considered to be either a recommendation by Schwab or a solicitation of any offer to purchase or sell any securities.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |